CD274 and neoplasm: Theoretically, OV-induced ICD should enhance the anti-tumor efficacy of ICI by increasing binding sites for ICIs (i.e., upregulating PD-L1 expression) specifically within the TME where OVs exert their lytic effects, and by prolonging ICI residence time.